Your device is not supported to view the app, please use landscape view or screen 320px or more.



Award recognises ground-breaking Liverpool work to help women with the Angelina Jolie gene

The so called "Angelina Jolie gene" is why the Hollywood actress had risk reducing surgery for her breasts, ovaries and fallopian tubes to reduce her risk of cancer. Women tend to be offered testing f...


NWC GMC behind 'genomic dream' to make DNA tests routine for patients

The North West Coast Genomic Medicine Centre (NWC GMC) was set up to gain a better understanding of the genetic causes of cancer and rare diseases and is in full support of making DNA tests routine fo...



An Introduction to Fetal Genomics

Who should attend: This event is aimed at Paediatricians, Neonatologists, Obstetricians, FetalMedicine Specialists & Midwives, Genetic Counsellors, Geneticists & Trainee Community Midwives, a...


Meanings, Mainstreaming & MDT's? 100,000 Genomes Results; Top tips for cancer clinicians

Who should attend: This event is for North West Coast NHS staff only, particularly thoseworking with cancer patients and involved in the 100,000 Genomes Project. The event will cover: 100K Genome...


Oncology & Immunotherapy Study Day

Who should attend: This event is aimed at members of the Cancer MDT specifically consultants,senior nurses, trainees & AHPs. Aims: To understand immunotherapy in cancer and its current knowle...


About Us

The North West Coast Genomic Medicine Centre (NWC GMC) has been set up to help gain a better understanding of the genetic causes of cancer and rare diseases. It is part of the government’s 100,000 Genomes Project, which aims to sequence, or analyse, 100,000 genomes from participants with cancer, rare disorders and infectious disease.

The NWC GMC represents a number of NHS organisations working together, led by Liverpool Women’s Hospital NHS Foundation Trust and supported by the Royal Liverpool and Broadgreen University Hospitals NHS Trust; The Walton Centre NHS Foundation Trust; Liverpool Heart and Chest Hospital NHS Foundation Trust; Alder Hey Children’s Hospital NHS Foundation Trust, the Countess of Chester NHS Foundation Trust, Lancashire Teaching NHS Foundation Trust, the North West Coast Academic Health Science Network and Liverpool Health Partners.  

The Centre forms part of a world-leading programme in the use of genomics and genetic technologies for participant benefit within the NHS. It will also be a major driver in ensuring that genomic medicine becomes main stream in the NHS associated with the move towards predicting and preventing disease, and more precisely diagnosing disease and personalising treatment.

The partnership will aim to recruit up to 8,000 patients who have been given a new diagnosis of diseases such as breast, lung or ovarian cancer. The initiative will then work to uncover patterns about specific genetic conditions.

There are between 6,000 and 8,000 known rare diseases worldwide.  Each disease or syndrome may affect less than 0.1% of the UK’s population, but cumulatively they affect the lives of 3 million people, and are associated with significant morbidity and mortality. 

The NWC GMC is responsible for recruiting and obtaining a sample of blood for the extraction of host DNA, as well as providing the participant's clinical data.